Our gratitude goes out to three OCRA Heroes who channeled their creative energy to champion our shared cause via inventive fundraising initiatives. Entrepreneur Daisy Garcia in California, personal care brand founder Julie Hogan in Florida, and artist Andrew Galdi in Pennsylvania have all been motivated to use their talents to contribute to the ovarian cancer … Continued
A recent study published in Nature Cancer talks about harnessing the power of machine learning to help predict prognosis and response to treatment for those with high-grade serous ovarian cancer (HGSOC). The study is co-authored by OCRA grantees Sohrab Shah, PhD, of Memorial Sloan Kettering Cancer Center – a two-time OCRA grant recipient, most recently … Continued
The following is a statement from The White House, published on July 13, 2022. Today, President Joe Biden announced his intent to appoint Dr. Mitchel Berger, Dr. Carol Brown, and Dr. Elizabeth Jaffee to the President’s Cancer Panel. The three are distinguished members of the scientific, research, and public health communities appointed by the President … Continued
We hope everyone is enjoying some sunshine while keeping cool and hydrated. OCRA is keeping busy – planning our Uniting for Hope Ovarian Cancer National Conference; offering support to patients and their loved ones; funding grantees and their quest for better treatments and a cure. Read on to see the latest. Research Advocacy Patient Support … Continued
In a promising development for our community, the House Appropriations Committee recently approved the fiscal year 2023 Labor, Health and Human Services, Education, and Related Agencies bill, which contains significant funding increases for key ovarian cancer programs. We urge the Senate to support these same FY23 program funding levels, which can make a crucial difference … Continued
Targeting a specific oncogene associated with the most common type of ovarian cancer may help increase a patient’s immune response to tumors, according to recent findings from researchers at The Wistar Institute and their colleagues at University of Pennsylvania and The University of Colorado Anschutz Medical Campus. An oncogene is a mutated version of a … Continued
Jessica lives in Manassas, Virginia, and was diagnosed with Sertoli-Leydig cell ovarian cancer. What has been your frustration in having a rare form of ovarian cancer? It took over 8 years to get diagnosed. Doctor after doctor dismissed me and categorized me into having PCOS. My endocrinologist knew something was wrong but couldn’t figure it … Continued
We hope everyone is keeping cool while feeling the warmth from our ovarian cancer community. And we hope to see many of your faces online this September when we host our Ovarian Cancer National Conference! Read below to find out details, along with other important news. Research Advocacy Patient Support Events Ways to Give Did you … Continued
Have you ever wished you could rewind and replay a confusing conversation with your doctor? Or needed help understanding the options and decisions ahead? Empower yourself with knowledge at our virtual National Conference, taking place September 21-23, 2022. Register today! Sign up to learn the most important information on research, treatment and care, directly from … Continued
OCRA has joined 71 other organizations in signing on to a letter calling for the U.S. Senate to incorporate critical reforms into the Prescription Drug User Fee Act (PDUFA) reauthorization which, if implemented, would improve diversity in clinical trials. These reforms, which are included as provisions in the U.S. House version, would make a number of … Continued
Recent OCRA-funded research has resulted in the creation of a new bioinformatics tool that holds potential for predicting the best treatment combinations for cancer patients. Bioinformatics is a scientific discipline that enables researchers to collect, process and analyze a vast amount of biological and medical data via computers and statistical techniques. In the case of … Continued
Dr. Sandra Cascio of Magee-Womens Research Institute is a 2021 recipient of OCRA’s Early Career Investigative Grant. With her project, “EGFL6 as a New Regulator of Myeloid Cell Expansion and Function in HGSOC,” Dr. Cascio seeks to better understand ovarian tumors’ microenvironments and, ultimately, to overcome ovarian cancer resistance to immunotherapy, opening up a new … Continued
Get email updates about research news, action alerts, and ways to join the fight.
